Skip to main content
Generix Group S.A. logo

Generix Group S.A. — Investor Relations & Filings

Ticker · GENX ISIN · FR0010501692 LEI · 9695003QNWHLC60H9E89 PA Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 466 across all filing types
Latest filing 2022-05-04 Major Shareholding Noti…
Country FR France
Listing PA GENX

About Generix Group S.A.

https://www.generixgroup.com/en

Generix Group is a global SaaS company that provides a portfolio of AI-powered, cloud-based solutions to streamline mission-critical digital processes in supply chain, finance, and commerce. The company's software suite is designed to help businesses build collaborative digital networks with their trading partners. Key offerings include Warehouse Management Systems (WMS), Transportation Management, B2B Integration, and automated invoice management. By digitizing the flow of goods and data, Generix Group enables organizations to optimize operations, enhance productivity, and manage end-to-end processes from procurement to payment and from order to delivery.

Recent filings

Filing Released Lang Actions
Franchissement de seuil
Major Shareholding Notification Classification · 99% confidence The document is titled "Déclaration de franchissement de seuil (article L. 233-7 du code de commerce)" and also mentions "Déclaration des achats et des ventes effectuées pendant une offre publique". It details a change in share ownership threshold crossing (franchissement de seuil) by the entity Amplegest, specifically noting a decrease below the 5% threshold due to a sale of shares. This type of filing, reporting changes in significant share ownership that cross regulatory thresholds, directly corresponds to the Major Shareholding Notification category (MRQ). The document is a formal regulatory declaration regarding shareholding changes.
2022-05-04 French
Franchissement de seuils
Major Shareholding Notification Classification · 99% confidence The document is titled "Déclaration de franchissement de seuils (article L. 233-7 du code de commerce)" which translates to "Declaration of crossing thresholds (Article L. 233-7 of the Commercial Code)". This type of filing in France specifically reports when an investor's stake in a listed company crosses certain ownership thresholds (like 5%, 10%, etc.). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant share ownership levels crossing thresholds. The French equivalent for this regulatory disclosure is best mapped to the 'Major Shareholding Notification' category (MRQ). The document is short and contains specific regulatory details, confirming it is a direct filing, not an announcement of a filing.
2022-05-02 French
Generix Group - Information relative au nombre total de droits de vote et d’actions au 31 mars 2022
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled "COMMUNIQUE FINANCIER" and explicitly states it provides "Information relative au nombre total de droits de vote et d'actions" (Information relative to the total number of voting rights and shares), referencing French commercial code and AMF (Autorité des Marchés Financiers) regulations. It presents a table showing the number of shares and theoretical voting rights as of a specific date (31/03/2022). This type of mandatory disclosure regarding the total share capital and voting rights structure is a specific regulatory filing, often related to capital structure or shareholder information, but it is not a full report (10-K, IR), an earnings release (ER), or a dividend notice (DIV). It most closely aligns with notifications concerning share capital changes or major shareholdings, but given the specific focus on the total count of voting rights, it fits best under the category related to share structure or regulatory updates. Since it is a direct, periodic disclosure of voting rights count, it is a specific regulatory announcement. Among the provided codes, 'SHA' (Share Issue/Capital Change) or 'MRQ' (Major Shareholding Notification) are possibilities, but the most precise fit for a mandatory disclosure of the total number of voting rights is often grouped with capital structure updates or general regulatory filings. Given the options, this is a direct notification about the capital structure's voting power, which is a specific type of regulatory filing. Since it is not a change in major shareholding (MRQ) but a total count, and not a general share issue (SHA), it falls under a specific regulatory disclosure. However, looking closely at the definitions, 'SHA' covers capital changes, and this is a fundamental capital structure metric. If a more specific code for 'Total Voting Rights' existed, it would be used. In the absence of that, this is a mandatory disclosure related to the share base. Let's re-evaluate the options. It is not a DVA (Declaration of Voting Results), as that is for the *results* of a vote, not the *potential* voting rights count. It is a periodic disclosure of the total share base. This type of filing is often classified as a 'Capital/Financing Update' (CAP) or a specific regulatory filing (RNS). Given the context of French mandatory disclosures on voting rights, this is a fundamental piece of information about the company's capital structure. Since it is a direct, short, mandatory disclosure, and not a general announcement of a report (RPA), I will classify it as a specific regulatory filing (RNS) or potentially related to capital structure (CAP). Since it is a formal, required disclosure of the share base, 'SHA' (Share Issue/Capital Change) is a plausible fit as it relates directly to the denominator of capital structure, even if no *change* is announced in this specific document, the disclosure itself is mandated by capital rules. However, 'RNS' (Regulatory Filings) is the safest fallback for specific, non-standard regulatory disclosures. Given the highly specific nature of the content (total voting rights count), and the lack of a perfect match, RNS is appropriate, but let's check if it fits CAP. CAP is for fundraising/financing activities. This is reporting existing structure. I will lean towards RNS as the most accurate catch-all for this specific regulatory metric disclosure that doesn't fit the other specific report types. Upon further review, many jurisdictions classify these mandatory voting rights disclosures under general regulatory announcements or sometimes under share capital notifications. Given the options, RNS is the most appropriate general regulatory filing code for this specific, short, mandatory disclosure that doesn't fit the other detailed report types (10-K, IR, ER, etc.). The document is short (1676 chars) and is a direct disclosure, not an announcement of a larger report (ruling out RPA).
2022-04-11 French
Acquisition of 100% of Generix Group Portugal
M&A Activity Classification · 99% confidence The document is a press release dated April 4, 2022, announcing a specific corporate action: the acquisition of 100% of its subsidiary, Generix Group Portugal. This action falls under corporate restructuring, mergers, or acquisitions. Reviewing the definitions, the 'M&A Activity' (Code: TAR) is defined as 'Announcements and documents related to merger proposals or takeover bids.' While this is an internal acquisition of a subsidiary stake rather than a traditional merger or takeover bid, it is the closest fit among the provided options for a significant transaction involving corporate control change. It is not an Earnings Release (ER), Interim Report (IR), or a general Regulatory Filing (RNS), as it details a specific strategic transaction. Given the nature of acquiring a controlling stake in another entity, TAR is the most appropriate classification.
2022-04-04 English
Acquisition de 100% de Generix Group Portugal
M&A Activity Classification · 99% confidence The document is a press release ("COMMUNIQUE DE PRESSE") dated April 4, 2022, announcing that Generix Group has acquired the remaining 50% stake in its Portuguese subsidiary, bringing its ownership to 100%. This action constitutes a change in corporate structure and ownership related to a subsidiary, which falls under corporate financing or structural changes. Reviewing the definitions, this event is most closely related to 'Capital/Financing Update' (CAP) as it involves a change in equity holding and corporate structure, or potentially 'Regulatory Filings' (RNS) if it were a mandatory filing without a better fit. Since it details a specific transaction affecting capital structure (acquiring full ownership), 'CAP' is the most appropriate fit among the specific categories, as it is a significant corporate transaction, even if not a traditional fundraising event. It is not an earnings release (ER), management change (MANG), or M&A involving an external target (TAR), but an internal consolidation of ownership.
2022-04-04 French
Generix Group - Information relative au nombre total de droits de vote et d’actions au 28 février 2022
Share Issue/Capital Change Classification · 95% confidence The document is titled "COMMUNIQUE FINANCIER" and explicitly states it provides "Information relative au nombre total de droits de vote et d'actions" (Information relative to the total number of voting rights and shares), citing French commercial code and AMF regulations (Article L. 233-8 II du Code de Commerce et l'article 223-16 du règlement général de l'Autorité des Marchés Financiers). It presents a table showing the total number of shares and theoretical voting rights as of a specific date (28/02/2022). This type of mandatory disclosure regarding the total share capital and voting rights is a specific regulatory filing, often related to capital structure or shareholder information, but it does not fit perfectly into the defined categories like SHA (Share Issue/Capital Change) or DVA (Declaration of Voting Results). Since it is a mandatory regulatory disclosure concerning the capital structure/voting rights count, and it is not a full report, a dividend notice, or a director's dealing, it falls best under the general regulatory announcement category, RNS, as it is a specific, periodic regulatory update not covered by other codes. However, given the content is strictly about the total number of shares and voting rights, it is a fundamental disclosure related to the capital base. If 'SHA' is interpreted broadly to include updates on the total share count, that might fit, but SHA is defined as 'New share issues, stock splits, or other capital changes.' This is a periodic count, not a change event. Therefore, RNS (Regulatory Filings) is the most appropriate fallback for this specific, non-standard regulatory disclosure.
2022-03-11 French

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.